Index S&P 500
P/E 29.76
EPS (ttm) 5.07
Insider Own 0.09%
Shs Outstand 458.37M
Perf Week -0.70%
Market Cap 69.01B
Forward P/E 23.42
EPS next Y 6.44
Insider Trans -8.58%
Shs Float 456.96M
Perf Month -10.09%
Income 2.34B
PEG 3.06
EPS next Q 1.34
Inst Own 95.72%
Short Float 0.70%
Perf Quarter -18.91%
Sales 8.54B
P/S 8.08
EPS this Y 8.60%
Inst Trans 0.02%
Short Ratio 0.94
Perf Half Y -9.38%
Book/sh 10.90
P/B 13.84
EPS next Y 11.49%
ROA 16.05%
Short Interest 3.18M
Perf Year -14.44%
Cash/sh 4.46
P/C 33.81
EPS next 5Y 9.73%
ROE 49.86%
52W Range 144.80 - 201.92
Perf YTD -23.55%
Dividend Est. 1.72 (1.14%)
P/FCF 42.57
EPS past 5Y 11.57%
ROI 19.95%
52W High -25.28%
Beta 0.87
Dividend TTM 1.61 (1.07%)
Quick Ratio 2.00
Sales past 5Y 8.05%
Gross Margin 68.28%
52W Low 4.20%
ATR (14) 4.67
Dividend Ex-Date Apr 18, 2024
Current Ratio 3.36
EPS Y/Y TTM 12.77%
Oper. Margin 35.92%
RSI (14) 34.73
Volatility 3.10% 2.55%
Employees 14100
Debt/Eq 1.36
Sales Y/Y TTM 5.74%
Profit Margin 27.43%
Recom 1.42
Target Price 220.42
Option/Short Yes / Yes
LT Debt/Eq 1.35
EPS Q/Q 15.54%
Payout 30.71%
Rel Volume 1.06
Prev Close 149.56
Sales Surprise 1.13%
EPS Surprise -5.80%
Sales Q/Q 8.48%
Earnings May 02 BMO
Avg Volume 3.39M
Price 150.88
SMA20 -5.34%
SMA50 -13.40%
SMA200 -16.24%
Trades
Volume 3,640,463
Change 0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-12-24 Reiterated
Stifel
Buy
$195 → $215
Dec-19-23 Resumed
Jefferies
Buy
$230
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$237
Sep-06-23 Initiated
HSBC Securities
Buy
$230
Jul-12-22 Initiated
Piper Sandler
Overweight
$205
Nov-18-21 Initiated
Morgan Stanley
Overweight
$40
Nov-18-21 Initiated
Morgan Stanley
Overweight
$264
Aug-05-21 Resumed
Credit Suisse
Outperform
$206
Jul-16-21 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-08-21 Upgrade
Raymond James
Mkt Perform → Outperform
$166
Mar-08-21 Upgrade
BofA Securities
Neutral → Buy
$180
Sep-21-20 Initiated
Atlantic Equities
Overweight
$191
Aug-14-20 Upgrade
Edward Jones
Hold → Buy
Aug-12-20 Downgrade
Gabelli & Co
Buy → Hold
May-27-20 Initiated
Jefferies
Buy
$152
Jan-10-20 Initiated
Raymond James
Mkt Perform
Sep-09-19 Initiated
Goldman
Buy
$145
Jul-01-19 Downgrade
BofA/Merrill
Buy → Neutral
$111 → $120
Jun-11-19 Initiated
Barclays
Overweight
$120
May-23-19 Initiated
Guggenheim
Buy
$114
Show Previous Ratings
Today 07:00AM
Apr-24-24 11:22AM
03:02AM
Apr-23-24 09:00PM
12:09PM
06:15PM
Loading…
Apr-22-24 06:15PM
03:20PM
Apr-19-24 09:44AM
07:53AM
07:37AM
07:23AM
Apr-17-24 07:02AM
Apr-15-24 06:15PM
11:03AM
Apr-12-24 08:20PM
05:02PM
Loading…
05:02PM
04:06PM
(Investor's Business Daily)
01:56PM
01:49PM
01:30PM
12:26PM
10:15AM
(The Wall Street Journal)
05:30AM
(The Wall Street Journal)
Apr-10-24 12:00AM
Apr-08-24 06:15PM
Apr-06-24 08:42PM
Apr-01-24 04:30PM
03:10AM
Mar-31-24 11:53AM
Mar-30-24 03:52PM
08:30AM
Loading…
Mar-28-24 08:30AM
Mar-27-24 04:26PM
Mar-26-24 10:27AM
09:34AM
09:30AM
Mar-14-24 11:30AM
Mar-12-24 07:01PM
Mar-07-24 06:28PM
Mar-05-24 08:30AM
02:56AM
Feb-26-24 09:45AM
Feb-24-24 10:00AM
Feb-22-24 12:43PM
Feb-21-24 08:30AM
Feb-15-24 08:53AM
Feb-14-24 02:35AM
(Thomson Reuters StreetEvents)
12:18AM
Feb-13-24 05:37PM
(Morningstar Research) -6.71%
04:37PM
03:30PM
01:21PM
11:22AM
10:00AM
09:37AM
08:43AM
08:10AM
07:35AM
07:07AM
(Associated Press Finance)
07:00AM
Feb-10-24 08:30AM
Feb-09-24 10:54AM
Feb-08-24 09:15AM
Feb-06-24 04:15PM
10:00AM
Jan-22-24 07:53AM
Jan-20-24 09:02AM
Jan-18-24 08:00AM
Jan-15-24 12:10PM
Jan-13-24 02:05PM
Jan-12-24 07:54AM
Jan-10-24 06:00AM
Dec-28-23 08:30AM
Dec-26-23 08:06PM
Dec-21-23 08:30AM
Dec-13-23 06:45PM
Dec-12-23 03:04PM
Dec-07-23 05:34PM
(Investor's Business Daily)
04:05PM
02:56PM
03:00AM
(Investor's Business Daily)
Nov-30-23 02:30PM
Nov-22-23 07:43PM
Nov-21-23 08:30AM
Nov-14-23 06:03AM
Nov-13-23 09:57PM
Nov-09-23 03:49AM
Nov-03-23 10:00AM
01:09AM
12:10AM
(Thomson Reuters StreetEvents)
Nov-02-23 05:00PM
03:26PM
02:30PM
12:51PM
12:13PM
08:52AM
08:41AM
07:22AM
(Associated Press Finance)
07:00AM
Oct-31-23 10:01AM
Oct-30-23 04:35PM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lagano Roxanne Executive Vice President Apr 18 '24 Sale 151.17 923 139,530 14,800 Apr 18 04:37 PM Lagano Roxanne Executive Vice President Mar 18 '24 Sale 173.33 923 159,984 15,723 Mar 18 04:33 PM Reed Willie M Director Mar 11 '24 Sale 182.68 1,370 250,265 9,994 Mar 12 04:19 PM PECK KRISTIN C Chief Executive Officer Feb 20 '24 Option Exercise 46.09 13,000 599,170 92,366 Feb 21 04:39 PM PECK KRISTIN C Chief Executive Officer Feb 20 '24 Sale 187.20 13,000 2,433,636 79,366 Feb 21 04:39 PM Lagano Roxanne Executive Vice President Feb 20 '24 Sale 187.30 923 172,878 16,646 Feb 21 04:38 PM Lagano Roxanne Executive Vice President Feb 13 '24 Sale 186.86 2,848 532,177 17,569 Feb 14 05:04 PM Lagano Roxanne Executive Vice President Feb 12 '24 Sale 197.74 363 71,780 20,417 Feb 14 05:04 PM Lagano Roxanne Executive Vice President Jan 18 '24 Sale 191.43 923 176,690 17,569 Jan 19 05:07 PM Lagano Roxanne Executive Vice President Dec 18 '23 Sale 198.14 923 182,883 18,492 Dec 19 04:33 PM Lagano Roxanne Executive Vice President Dec 14 '23 Sale 200.00 2,500 500,000 19,415 Dec 14 04:55 PM PECK KRISTIN C Chief Executive Officer Nov 21 '23 Option Exercise 46.09 13,000 599,170 69,843 Nov 21 04:41 PM PECK KRISTIN C Chief Executive Officer Nov 21 '23 Sale 176.84 13,000 2,298,856 56,843 Nov 21 04:41 PM Lagano Roxanne Executive Vice President Nov 17 '23 Sale 177.46 923 163,796 22,665 Nov 20 04:45 PM Lagano Roxanne Executive Vice President Oct 18 '23 Sale 172.92 923 159,605 23,588 Oct 19 04:07 PM Lagano Roxanne Executive Vice President Sep 18 '23 Sale 179.58 923 165,752 24,511 Sep 18 04:25 PM Chen Heidi C. Executive Vice President Sep 15 '23 Sale 180.15 9,905 1,784,386 27,478 Sep 18 04:15 PM Lagano Roxanne Executive Vice President Sep 01 '23 Sale 192.97 923 178,111 25,434 Sep 05 05:04 PM PECK KRISTIN C Chief Executive Officer Aug 22 '23 Option Exercise 45.35 13,000 589,585 69,843 Aug 22 04:21 PM PECK KRISTIN C Chief Executive Officer Aug 22 '23 Sale 179.97 13,000 2,339,564 56,843 Aug 22 04:21 PM Polzer Robert J Executive Vice President Aug 09 '23 Option Exercise 144.03 1,179 169,811 3,532 Aug 11 04:32 PM Polzer Robert J Executive Vice President Aug 09 '23 Sale 189.94 1,179 223,939 2,353 Aug 11 04:32 PM PECK KRISTIN C Chief Executive Officer May 23 '23 Option Exercise 41.83 13,000 543,790 69,843 May 25 04:13 PM PECK KRISTIN C Chief Executive Officer May 23 '23 Sale 176.56 13,000 2,295,335 56,843 May 25 04:13 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite